Cannabis Law Report

SEPTEMBER 23, 2022

Senate Bill 519 would have decriminalized the personal possession of certain psychedelic substances, legalized life-saving public health interventions, and studied future approaches to increasing use of psychedelics. Policy and Advocacy Director, MAPS . As a result, the soon-to-be-amended version of SB 519 is limited to a study.”.

Decriminalization 52

Decriminalization Advocacy Research and Development Education 52

NORML

JANUARY 4, 2019

Separate provisions in the bill exclude cannabidiol from the federal definition of marijuana, permit VA doctors to authorize medical cannabis access to qualified patients, and remove undue federal barriers to clinical trial research to better assess the safety and efficacy of medical cannabis.

Legislation 125

Legislation Clinical Trials Research and Development Access 125

The Cannigma

MAY 7, 2021

Now, that’s going to matter significantly when as we advance clinical trials, as we advance product formulation as not just product formulation within pharma but all product formulation and that comes down to the initial process in relation to the supply chain of pretty hardcore standardization. MSO: Let’s pivot for a minute.

Supply Chain 120

Supply Chain Patients Access Hemp 120